For further details see:
Dyadic Int’l (DYAI) Inks Deal Toward Potential Access to 40% of the World as Covid Vaccine Continues in DevelopmentFor further details see:
Dyadic Int’l (DYAI) Inks Deal Toward Potential Access to 40% of the World as Covid Vaccine Continues in DevelopmentMarket Wire News is a media platform, the information on this page was provided by Wall Street PR News via Quote Media. Read our full disclaimer.
When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.
Be alerted of any news about your stocks and see what other stocks are trending.
News, Short Squeeze, Breakout and More Instantly...
2024-08-02 16:15:04 ET Guggenheim analyst issues NEUTRAL recommendation for MRNA on August 2, 2024 02:22PM ET. The previous analyst recommendation was Neutral. MRNA was trading at $85.46 at issue of the analyst recommendation. The overall analyst consensus : BUY. Cur...
2024-08-02 10:20:00 ET August 2, 2024 (Investorideas.com Newswire) Investorideas.com , a go-to investing platform covering biotech and nanotechnology issues a snapshot looking at news and developments in the antiviral market, featuring NanoViricides, Inc. ( NYSE American: NNVC )...
2024-08-01 12:45:13 ET Image source: The Motley Fool. Moderna (NASDAQ: MRNA) Q2 2024 Earnings Call Aug 01, 2024 , 8:00 a.m. ET Operator Continue reading For further details see: Moderna (MRNA) Q2 2024 Earnings Call Transcript